PRESIDENT AND COO · UNITED THERAPEUTICS Corp · Common Stock
Side
SELL
Value
$7.35M
Shares
14.6K
Price
$502.79
Executed
Dec 29, 2025
Disclosed
Dec 30, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Dec 29 executedDec 30, 2025 disclosed
UTHR · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Benkowitz Michael filed this Form 4 reporting a open-market sale of UTHR on Dec 29, 2025. It became public on Dec 30, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
PRESIDENT AND COO
Benkowitz Michaelcik:0001673232
Issuer
UNITED THERAPEUTICS Corpcik:0001082554
Revision history · 0
No field has changed since this record was first ingested.
